Dr. Ramesh GrandhiUSA
University of Utah
| 2018 to present | University of Utah |
| 2018 - Current | University of Utah |
| 2015 - 2018 | University of Texas Health San Antonio |
| 2019 - Current | AANS/CNS Executive Committee on Neurotrauma & Critical Care |
Neurotrauma, Cerebrovascular, Endovascular
Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma
1108 14:30-14:40
Cerebrovascular/304B
Chronic subdural hematoma (cSDH) is estimated to become the most commonly encountered neurosurgical pathology in the Western world by the year 2030. The increasing number of geriatric aged patients and inherent risk factors such as polypharmacy and fall risks make this pathology potentially even more prevalent in future years. Minimally invasive strategies to mitigate surgical recurrence and decrease need for surgical intervention are important from the public health standpoint. Middle meningeal artery embolization (MMAe) has been demonstrated to be safe and effective for treatment of cSDH. The focus of this lecture is to discuss the existing evidence behind this procedure and highlight opportunities for future investigation.
Endovascular Mechanical Thrombectomy for Acute Ischemic Stroke: Current State & A Roadmap for the Future
1108 16:50-17:00
Cerebrovascular/304B
Endovascular mechanical thrombectomy (EVT) has been a revolutionary procedure in the care of patients with acute ischemic stroke. From its humble beginnings and initial trials not demonstrating therapeutic benefit, improvements in patient selection and technological innovation along with numerous trials have demonstrating safety and efficacy in patients presenting with intracranial vessel occlusions, have lead to this procedure being widely adopted across the world. The focus of this lecture is to review the data that led to where we currently are with regards to EVT for intracranial vessel occlusions and highlight where future investigations and frontiers lie.